Minority AIDS Initiative: Substance Use Disorder (SUD) Prevention and Treatment Pilot Program
ID: 352060Type: Posted
Overview

Buyer

Substance Abuse and Mental Health Services Adminis (HHS-SAMHS-SAMHSA)

Award Range

$0 - $700K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled the Minority AIDS Initiative: Substance Use Disorder (SUD) Prevention and Treatment Pilot Program. This program aims to provide comprehensive substance use prevention and treatment services, as well as HIV and viral hepatitis prevention and treatment, specifically targeting racial and ethnic individuals who are vulnerable to SUD and related health conditions. The initiative emphasizes a syndemic approach, addressing the interconnectedness of SUD, HIV, and viral hepatitis among at-risk populations. Eligible applicants include states, territories, tribal organizations, health facilities, and non-profit entities, with a total estimated funding of $5.7 million available for approximately eight awards, each ranging from $0 to $700,000. Interested parties should note that the application deadline is July 12, 2024, and can reach out to the MAI Programmatic Team at MAI-Braided@samhsa.hhs.gov for further inquiries.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    Rural Opioid Technical Assistance Regional Centers
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Rural Opioid Technical Assistance Regional Centers." This program aims to establish regional centers of excellence that will provide training and technical assistance to combat opioid and stimulant misuse in rural communities. The initiative is crucial for addressing the growing health crisis related to substance abuse in these areas, with an estimated total program funding of $7,150,000 and the expectation of awarding 11 grants. Interested applicants, including public or nonprofit entities, states, Indian tribes, and health facilities, can reach out to Twyla Adams at (240) 276-1576 or via email at twyla.adams@samhsa.hhs.gov for further information. The opportunity is currently posted, with an estimated synopsis posting date of May 1, 2025.
    Targeted Capacity Expansion – Special Projects
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Targeted Capacity Expansion – Special Projects," aimed at enhancing the provision of substance use disorder (SUD) and co-occurring disorder (COD) services for under-resourced populations. The program seeks to implement targeted strategies for harm reduction, treatment, and recovery support services to address unmet community needs. With an estimated total program funding of $8 million and the expectation of awarding 21 grants, this initiative is crucial for improving health outcomes in communities facing substance use challenges. Interested applicants, which include domestic public and private nonprofit entities, can reach out to Angelica Ramirez at angelica.ramirez@samhsa.hhs.gov or (240) 276-1581 for further information, with the synopsis expected to be posted on November 15, 2024.
    Family Support Technical Assistance Center
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Family Support Technical Assistance Center." This program aims to enhance training and education for both the general public and healthcare practitioners regarding the significance of family supports and services, particularly in integrating these services into mental and substance use disorder treatment programs. The initiative is crucial for improving the overall effectiveness of treatment by emphasizing the role of family involvement. The estimated total program funding is $800,000, with one award anticipated. Interested applicants, who must be domestic public and private non-profit entities, can reach out to Jessica Mullins at jessica.mullins@samhsa.hhs.gov or call 240-276-1653 for further information. The synopsis for this opportunity is expected to be posted by February 28, 2025.
    Addiction Technology Transfer Centers Cooperative Agreement
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Addiction Technology Transfer Centers Cooperative Agreement" aimed at enhancing the behavioral healthcare and primary healthcare workforce for substance use disorder (SUD) treatment and recovery support services. This initiative seeks to accelerate the adoption of evidence-based practices, improve workforce knowledge and skills, and foster collaborations among diverse stakeholders in the field of substance use and co-occurring health disorders. With an estimated total program funding of $8.6 million and an expected 12 awards, eligible applicants include states, territories, Indian tribes, and nonprofit entities. Interested parties can reach out to Humberto Carvalho at Humberto.Carvalho@samhsa.hhs.gov or (240) 276-2974 for further information, with the synopsis expected to be posted on January 30, 2023.
    High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)" aimed at supporting innovative research that addresses the intersection of HIV and substance use. This initiative invites applications from individual researchers and research teams to develop projects that can lead to new prevention, treatment, and care strategies for individuals affected by both conditions, with a requirement for a detailed research plan and preliminary data. A total budget of $3.0 million is available for funding one to two awards, with individual project budgets capped at $1.5 million per fiscal year, and applications are due by February 12, 2027. Interested applicants can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries and are encouraged to consult with NIDA program staff early in the application process.
    Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders" through the R01 Research Project Grant. This initiative aims to support innovative and high-risk studies that explore the molecular mechanisms linking HIV and substance use disorders (SUDs), with a focus on advancing understanding of HIV dynamics within the Central Nervous System (CNS). The total estimated program funding is $2 million for fiscal year 2026, with the potential to support up to three awards, and applications must include clear milestones and human or primate studies. Interested applicants should note that the deadline for submitting letters of intent and applications is July 14, 2025, and no clinical trials are permitted under this grant. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)" aimed at accelerating the development of medications for Substance Use Disorders (SUDs). This initiative encourages research applications that support a diverse range of preclinical and clinical projects, with the goal of advancing medication studies toward FDA approval, emphasizing the importance of innovative approaches to drug misuse and addiction treatment. Eligible applicants include a variety of institutions, such as higher education entities and community organizations, with funding available up to $5 million per year for projects lasting up to three years. Interested parties can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by August 11, 2025.
    Enhancement and Expansion of Treatment and Recovery Services for Adolescents, Transitional Aged Youth, and their Families
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Enhancement and Expansion of Treatment and Recovery Services for Adolescents, Transitional Aged Youth, and their Families." This program aims to enhance and expand comprehensive treatment, early intervention, and recovery support services for adolescents aged 12-18 and transitional aged youth aged 16-25 who are facing substance use disorders and/or co-occurring mental health disorders, along with their families or primary caregivers. The initiative is crucial for addressing the growing need for effective support systems in mental health and substance use treatment for young individuals. The estimated total program funding is $800,000, with one award expected, and interested applicants can reach out to Andrea Harris at andrea.harris@samhsa.hhs.gov or (240) 276-2441 for further information. The synopsis is anticipated to be posted on December 16, 2024, for the fiscal year 2025.
    Provider’s Clinical Support System – Medication Assisted Treatment Grant
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Provider’s Clinical Support System – Medication Assisted Treatment Grant" aimed at expanding training for primary care providers in the prevention and treatment of opioid use disorders (OUD) and chronic pain management. This grant seeks to enhance understanding and access to medication-assisted treatment (MAT) through the training of providers authorized to prescribe FDA-approved schedule III medications for addictive disorders, specifically targeting national professional medical organizations such as ASAM, AAAP, AMA, AOAAM, and APA. With an estimated total program funding of $2,000,000 and the expectation of one award, interested applicants can reach out to Humberto Carvalho at Humberto.Carvalho@samhsa.hhs.gov or (240) 276-2974 for further details. The synopsis for this opportunity is expected to be posted on February 15, 2022.
    National Technical Assistance Center for Child, Youth and Family Mental Health
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "National Technical Assistance Center for Child, Youth and Family Mental Health." This program aims to provide training and technical assistance to enhance access to and the effectiveness of evidence-based mental health services for children, youth, and young adults (up to age 21) experiencing Serious Emotional Disturbances or Serious Mental Illness, along with their families. The initiative is crucial for promoting the coordination of mental health services, ensuring that vulnerable populations receive the support they need. The estimated total program funding is $3,000,000, with one award anticipated. Interested applicants, who must be domestic public or private non-profit entities, can reach out to Kathryn Perrotta at kathryn.perrotta@samhsa.hhs.gov or call 240-276-1903 for further information. The application period is open until March 15, 2025, with the synopsis posted on December 10, 2024.